Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Asset Writedowns and Impairment (2023 - 2024)

Adagio Medical Holdings (ADGM) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with -$15000.0 as the latest value for Q3 2024.

  • Quarterly Asset Writedowns and Impairment changed N/A to -$15000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $30000.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $25000.0 for FY2023, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q3 2024 was -$15000.0 at Adagio Medical Holdings, up from -$41000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $82000.0 in Q1 2024, with the low at -$41000.0 in Q2 2024.